Paxlovid — the most widely-used medication that people can take at home to treat an active case of Covid — is now being studied as a potential treatment for those who have remained sick months or even years following infection.
Screening nearly 1 million patients, visitors, and healthcare workers at the entrance of a large hospital for COVID-19 symptoms, exposures, or travel was of limited benefit at considerable cost, finds a Yale study published yesterday in JAMA Internal Medicine.
Today in Annals of Internal Medicine, researchers show that, compared to 2020, mortality rates due to COVID-19 infections among young adults increasedsignificantly in 2021, suggesting younger people had lower vaccine uptake and adhered to fewer COVID precautions than older adults in the United States
Recent Comments